These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23027972)

  • 1. Using intein catalysis to probe the origin of major histocompatibility complex class I-presented peptides.
    Farfán-Arribas DJ; Stern LJ; Rock KL
    Proc Natl Acad Sci U S A; 2012 Oct; 109(42):16998-7003. PubMed ID: 23027972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-examining class-I presentation and the DRiP hypothesis.
    Rock KL; Farfán-Arribas DJ; Colbert JD; Goldberg AL
    Trends Immunol; 2014 Apr; 35(4):144-52. PubMed ID: 24566257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance.
    Dolan BP; Li L; Veltri CA; Ireland CM; Bennink JR; Yewdell JW
    J Immunol; 2011 Feb; 186(4):2065-72. PubMed ID: 21228349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?
    Yewdell JW; Antón LC; Bennink JR
    J Immunol; 1996 Sep; 157(5):1823-6. PubMed ID: 8757297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous presentation of a nascent antigenic epitope to CD8+ CTL is more efficient than exogenous presentation.
    Hahn YS; Hahn CS; Braciale TJ
    Immunol Cell Biol; 1996 Oct; 74(5):394-400. PubMed ID: 8912001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-presentation: underlying mechanisms and role in immune surveillance.
    Rock KL; Shen L
    Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide Channeling: The Key to MHC Class I Immunosurveillance?
    Yewdell JW; Dersh D; Fåhraeus R
    Trends Cell Biol; 2019 Dec; 29(12):929-939. PubMed ID: 31662235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitating protein synthesis, degradation, and endogenous antigen processing.
    Princiotta MF; Finzi D; Qian SB; Gibbs J; Schuchmann S; Buttgereit F; Bennink JR; Yewdell JW
    Immunity; 2003 Mar; 18(3):343-54. PubMed ID: 12648452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action.
    Lev A; Princiotta MF; Zanker D; Takeda K; Gibbs JS; Kumagai C; Waffarn E; Dolan BP; Burgevin A; Van Endert P; Chen W; Bennink JR; Yewdell JW
    Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6964-9. PubMed ID: 20351281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway.
    Shastri N; Cardinaud S; Schwab SR; Serwold T; Kunisawa J
    Immunol Rev; 2005 Oct; 207():31-41. PubMed ID: 16181325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate-induced protein stabilization reveals a predominant contribution from mature proteins to peptides presented on MHC class I.
    Colbert JD; Farfán-Arribas DJ; Rock KL
    J Immunol; 2013 Dec; 191(11):5410-9. PubMed ID: 24174619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.
    Yewdell JW
    Trends Immunol; 2011 Nov; 32(11):548-58. PubMed ID: 21962745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products.
    Qian SB; Reits E; Neefjes J; Deslich JM; Bennink JR; Yewdell JW
    J Immunol; 2006 Jul; 177(1):227-33. PubMed ID: 16785518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-conventional sources of peptides presented by MHC class I.
    Starck SR; Shastri N
    Cell Mol Life Sci; 2011 May; 68(9):1471-9. PubMed ID: 21390547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune surveillance via self digestion.
    Schmid D; Münz C
    Autophagy; 2007; 3(2):133-5. PubMed ID: 17204851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism.
    Malarkannan S; Horng T; Shih PP; Schwab S; Shastri N
    Immunity; 1999 Jun; 10(6):681-90. PubMed ID: 10403643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the Deubiquitinase Usp14 Diminishes Direct MHC Class I Antigen Presentation.
    Palmer AL; de Jong A; Leestemaker Y; Geurink PP; Wijdeven RH; Ovaa H; Dolan BP
    J Immunol; 2018 Feb; 200(3):928-936. PubMed ID: 29282303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation, translocation, and presentation of MHC class I-restricted peptides.
    Heemels MT; Ploegh H
    Annu Rev Biochem; 1995; 64():463-91. PubMed ID: 7574490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide-bound major histocompatibility complex class I molecules associate with tapasin before dissociation from transporter associated with antigen processing.
    Li S; Paulsson KM; Sjögren HO; Wang P
    J Biol Chem; 1999 Mar; 274(13):8649-54. PubMed ID: 10085102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes.
    Schubert U; Antón LC; Gibbs J; Norbury CC; Yewdell JW; Bennink JR
    Nature; 2000 Apr; 404(6779):770-4. PubMed ID: 10783891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.